Journal of the National Cancer Institute
Study showed oxaliplatin improved colon cancer patient survival
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published ...
Cancer
Jan 20, 2012 |
not rated yet |
0
Predicting the value of indexing symptoms for ovarian cancer
The use of symptom indices to identify patients with symptoms associated with ovarian cancer who may need further screening is increasing in both the UK and the US in an attempt to promote earlier diagnosis, but they may ...
Cancer
Jan 14, 2012 |
not rated yet |
0
|
Autologous stem cell transplantation does not improve os in patients with follicular lymphoma
High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy ...
Cancer
Dec 21, 2011 |
not rated yet |
0
Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy
Accelerated partial breast irradiation using brachytherapy (APBIb) for the treatment of breast cancer has been rapidly increasing over the last several years in the U.S. as an alternative to standard whole-breast irradiation ...
Cancer
Dec 16, 2011 |
not rated yet |
0
Cancer screening reform needed
Since the National Cancer Institute developed the first guidelines on mammography screening over thirty years ago, advocacy and professional groups have developed guidelines focused on who should be screened, instead of communicating ...
Cancer
Nov 21, 2011 |
not rated yet |
0
Fecal occult blood testing effective in colonoscopy screenings
Fecal immunochemical testing (FIT) is more effective in its health benefits at the same or lower costs compared to guaiac fecal occult blood testing (gFOBT) at all levels of colonoscopy capacity, according to a study published ...
Cancer
Nov 09, 2011 |
4 / 5 (1) |
0
Concurrent chemo and radiation confers survival benefit in nasopharyngeal carcinoma patients
The combination of chemotherapy and radiation significantly improved the 5-year overall survival of patients with stage II nasopharyngeal carcinoma (NPC), according to a phase III study published Nov. 4 in the Journal of ...
Cancer
Nov 05, 2011 |
not rated yet |
0
European studies on risks of hepatocellular carcinoma
Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to ...
Cancer
Oct 21, 2011 |
not rated yet |
1
Antineoplastic agents associated with thyroid dysfunction
Antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction in 20%-50% of cancer patients taking them, which can ...
Cancer
Oct 18, 2011 |
not rated yet |
0
Survival disparities in African-American and white colo-rectal cancer patients
African-American patients with resected stage II and stage III colon cancer experienced worse overall and recurrence-free survival compared to whites, but similar recurrence-free intervals, according to a study published ...
Cancer
Oct 12, 2011 |
not rated yet |
0
Company stock prices before public announcements of oncology trial results
Prior knowledge of phase III clinical trials of new drugs and Food and Drug Administration (FDA) regulatory decisions may affect the price of a drug company's stock according to a study published September 26 in the Journal of ...
Other
Sep 26, 2011 |
not rated yet |
0
Improving cancer communication to patients
Oncologists and their patients are increasingly challenged with making difficult decisions about screening, prevention and treatment. Unfortunately, most patients are neither armed with adequate knowledge nor the means of ...
Cancer
Sep 19, 2011 |
not rated yet |
0
Fewer than three doses of cervical cancer vaccine effective
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study ...
Cancer
Sep 09, 2011 |
not rated yet |
0
Modeling disparities may help with cervical cancer prevention
Researchers reported that explicit inclusion of disparities in cost-effectiveness analysis, would allow policy makers to identify strategies that would reduce overall cancer risk, reduce disparities between racial ethnic ...
Cancer
Sep 06, 2011 |
not rated yet |
0
Screening for HPV persistence and cervical cancer risk
Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Ca ...
Cancer
Sep 06, 2011 |
not rated yet |
0
